ImmunoPrecise Launches DeepDisplay Antibody Discovery Platform

- April 2nd, 2019

ImmunoPrecise (TSXV:IPA, OTC Pink:IPATF) has announced the launch of DeepDisplay, a combination of transgenic animal immunization and custom phage display antibody selections. As quoted in the press release: ImmunoPrecise has launched, in response to a large-scale discovery program with an unnamed, US-based Pharma company, a powerful and unique platform for therapeutic antibody discovery proven to … Continued

ImmunoPrecise (TSXV:IPA, OTC Pink:IPATF) has announced the launch of DeepDisplay, a combination of transgenic animal immunization and custom phage display antibody selections.

As quoted in the press release:

ImmunoPrecise has launched, in response to a large-scale discovery program with an unnamed, US-based Pharma company, a powerful and unique platform for therapeutic antibody discovery proven to be successful in delivering a sequence-diverse human antibody panel with broad species cross-reactivity (e.g. mouse, primate, human). The combination of a transgenic animal immunization with phage display antibody selection used in DeepDisplay™ delivers the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of success compared to conventional technologies.

“The ability to select needle-in-the-haystack antibodies using this powerful combination of OmniAb® rodent (mouse or rat) immunization and phage display antibody selections provide an entirely new avenue in therapeutic antibody discovery.” said Debby Kruijsen, Ph.D., General Manager of ModiQuest® Research.

Jennifer Bath, Ph.D., CEO of ImmunoPrecise added: “With over 15 years of experience in customized and precision-based phage display, IPA has coupled this powerful technology with Ligand’s OmniAb™ transgenic rodent platforms to enable the accelerated discovery of highly diverse, fully human antibodies with superior clinical safety and efficacy and the lowest immunogenicity.”

Click here to read the full press release.

  Life Science and Healthcare Investing report cover

Life Science and Healthcare Investing in 2021

 
The life science and healthcare market is a booming, multi-billion dollar industry. Read our 2021 life science outlook report!
 

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All

Tags

Tags:

Leave a Reply